Jacobs IJ - Search Results

1

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Kjaerbye-Thygesen A, Gayther S, Jacobs IJ, Høgdall CK. Høgdall EV, et al. Among authors: jacobs ij. Gynecol Oncol. 2007 Mar;104(3):508-15. doi: 10.1016/j.ygyno.2006.09.028. Epub 2006 Nov 17. Gynecol Oncol. 2007. PMID: 17113137

2

Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses.

Woolas RP, Conaway MR, Xu F, Jacobs IJ, Yu Y, Daly L, Davies AP, O'Briant K, Berchuck A, Soper JT, et al. Woolas RP, et al. Among authors: jacobs ij. Gynecol Oncol. 1995 Oct;59(1):111-6. doi: 10.1006/gyno.1995.1276. Gynecol Oncol. 1995. PMID: 7557595 Clinical Trial.

3

OVX1 radioimmunoassay results are dependent on the method of sample collection and storage.

Hogdall EV, Hogdall CK, Kjaer SK, Xu F, Yu Y, Bast RC, Blaakaer J, Jacobs IJ. Hogdall EV, et al. Among authors: jacobs ij. Clin Chem. 1999 May;45(5):692-4. Clin Chem. 1999. PMID: 10222361 No abstract available.

4

Increased mortality in postmenopausal women with serum CA125 elevation.

Jeyarajah AR, Ind TE, MacDonald N, Skates S, Oram DH, Jacobs IJ. Jeyarajah AR, et al. Among authors: jacobs ij. Gynecol Oncol. 1999 May;73(2):242-6. doi: 10.1006/gyno.1999.5350. Gynecol Oncol. 1999. PMID: 10329041 Clinical Trial.

5

Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.

Menon U, Talaat A, Rosenthal AN, Macdonald ND, Jeyerajah AR, Skates SJ, Sibley K, Oram DH, Jacobs IJ. Menon U, et al. Among authors: jacobs ij. BJOG. 2000 Feb;107(2):165-9. doi: 10.1111/j.1471-0528.2000.tb11685.x. BJOG. 2000. PMID: 10688498

6

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.

Hogdall EV, Høgdall CK, Tingulstad S, Hagen B, Nustad K, Xu FJ, Bast RC, Jacobs IJ. Hogdall EV, et al. Among authors: jacobs ij. Int J Cancer. 2000 Nov 20;89(6):519-23. Int J Cancer. 2000. PMID: 11102897

7

A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro.

Li NF, Wilbanks G, Balkwill F, Jacobs IJ, Dafou D, Gayther SA. Li NF, et al. Among authors: jacobs ij. Lab Invest. 2004 Jul;84(7):923-31. doi: 10.1038/labinvest.3700093. Lab Invest. 2004. PMID: 15077121 Free article.

8

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.

Høgdall EV, Ryan A, Kjaer SK, Blaakaer J, Christensen L, Bock JE, Glud E, Jacobs IJ, Høgdall CK. Høgdall EV, et al. Among authors: jacobs ij. Cancer. 2004 Jun 1;100(11):2387-95. doi: 10.1002/cncr.20213. Cancer. 2004. PMID: 15160342 Free article.

9

STK15 polymorphisms and association with risk of invasive ovarian cancer.

Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H, McGuire V, Hogdall E, Shah MN, Luben RN, Easton DF, Jacobs IJ, Ponder BA, Whittemore AS, Gayther SA, Pharoah PD, Kruger-Kjaer S. Dicioccio RA, et al. Among authors: jacobs ij. Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1589-94. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15466974

10

A molecular genetic and statistical approach for the diagnosis of dual-site cancers.

Brinkmann D, Ryan A, Ayhan A, McCluggage WG, Feakins R, Santibanez-Koref MF, Mein CA, Gayther SA, Jacobs IJ. Brinkmann D, et al. Among authors: jacobs ij. J Natl Cancer Inst. 2004 Oct 6;96(19):1441-6. doi: 10.1093/jnci/djh272. J Natl Cancer Inst. 2004. PMID: 15467033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters